logo

For the Inventor, By the Inventor

Vadodara, India

Rajeev Budhdev Rehani

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajeev Budhdev Rehani. Retrieved from https://idiyas.com/inventor/rajeev-budhdev-rehani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 20.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Akota, IN (2009)
  • Baroda, IN (2005 - 2017)

Company Filing History:

goldMedal5 out of 155 
 
Sun Pharmaceutical Industries Limited
 patents

Years Active: 2005-2017

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9688667 - Tazarotene with low dimer impurity for treating acne or psoriasis (2017-06-27),
2. 7550605 - Process for preparation of an anitdepressant compound (2009-06-23),
3. 7482471 - Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-2-ol (2009-01-27),
4. 7132444 - Process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl]amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide (2006-11-07),
5. 6906062 - Crystalline form I of 2-methyl-4-(4-menthyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine (2005-06-14),

Title: Rajeev Budhdev Rehani: Innovator in Pharmaceutical Sciences

Introduction

Rajeev Budhdev Rehani is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds for treating various medical conditions. With a total of 5 patents to his name, his work continues to impact the industry positively.

Latest Patents

One of his latest patents involves Tazarotene with low dimer impurity for treating acne or psoriasis. This invention relates to a method of treating these skin conditions by topically administering Tazarotene that is substantially free of dimer impurity. The specific formula used is 4,4-dimethyl-6-[4-(4,4-dimethylthiochroman-6-yl)-buta-1,3-diynyl]-thiochroman. Another significant patent is for a process for preparing an antidepressant compound. This invention provides optically pure (S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine, along with a process for preparing an acid addition salt of this compound.

Career Highlights

Rajeev is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Sun Pharmaceutical has allowed him to focus on innovative drug development, contributing to the company's reputation for excellence in the pharmaceutical sector.

Collaborations

Rajeev has collaborated with several professionals in his field, including Rajamannar Thennati and Vijay Chhangamal Chhabada. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Rajeev Budhdev Rehani's contributions to pharmaceutical sciences through his patents and work at Sun Pharmaceutical Industries Limited highlight his role as a key innovator in the industry. His ongoing research and development efforts continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…